ClearPoint Neuro (NASDAQ: CLPT)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-08 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.180 | -0.180 | 0.0000 | ||||
REV | 5.080M | 5.200M | 120.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ClearPoint Neuro (NASDAQ: CLPT) through any online brokerage.
Other companies in ClearPoint Neuro’s space includes: Axogen (NASDAQ:AXGN), SI-BONE (NASDAQ:SIBN), Sight Sciences (NASDAQ:SGHT), Apollo Endosurgery (NASDAQ:APEN) and Semler Scientific (NASDAQ:SMLR).
The latest price target for ClearPoint Neuro (NASDAQ: CLPT) was reported by B. Riley Securities on Tuesday, April 5, 2022. The analyst firm set a price target for 15.00 expecting CLPT to rise to within 12 months (a possible 2.18% upside). 1 analyst firms have reported ratings in the last year.
The stock price for ClearPoint Neuro (NASDAQ: CLPT) is $14.6801 last updated Today at August 17, 2022, 5:15 PM UTC.
There are no upcoming dividends for ClearPoint Neuro.
ClearPoint Neuro’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for ClearPoint Neuro.
ClearPoint Neuro is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.